Alexion Antibody Technologies, Inc. Company Profile

21:00 EDT 25th September 2018 | BioPortfolio

Alexion Antibody Technologies, Inc. (AAT) is a wholly owned subsidiary of Alexion Pharmaceuticals [ALXN]. AAT is engaged in discovering and developing a portfolio of antibody therapeutics targeting severe unmet medical needs including cancer, autoimmune disorders, and inflammation. AAT was formed in September 2000 from the merger of the discovery platform of Prolifaron, Inc. with the established antibody development capacity of Alexion Pharmaceuticals, forming a powerhouse in antibody discovery and development. Alexion is approaching full integration, from discovery through commercialization.


3985 Sorrento Valley Blvd Ste, A
San Diego
United States of America


Phone: (858) 550-3490
Fax: (858) 550-3498

News Articles [822 Associated News Articles listed on BioPortfolio]

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum ...

Alexion's Soliris successor aces two phase 3 trials

Alexion’s new drug for a rare blood disease has hit the mark in two Phase 3 clinical studies - just days after it emerged that EU regulators may overturn a patent on its rare diseases blockbuster So...

Alexion to acquire Wilson Therapeutics in $855m deal

Alexion Pharmaceuticals has announced that it will acquire Swedish biopharmaceutical company Wilson Therapeutics for $855m. Alexion has made a recommended...Read More... The post Alexion to acquire Wi...

Alexion Purchases Wilson Therapeutics for $855M: Expands Pipeline

Alexion Pharmaceuticals is buying Wilson Therapeutics for $855 million. With the company, Alexion will acquire WTX101, Wilson Therapeutics’ Phase III compound for Wilson disease.

Alexion Pharma To Buy Sweden's Wilson Therapeutics For $855 Mln In Cash

STOCKHOLM (dpa-AFX) - Alexion Pharmaceuticals, Inc. (ALXN) announced Wednesday that it has made a recommended public cash offer to buy Sweden-based Wilson Therapeutics AB. Alexion has offered 232 ...

Alexion Acquires Swedish Treatment for Wilson’s Disease

Alexion Pharmaceutical intends to buy Wilson Therapeutics, a biotech developing a first-in-class treatment for Wilson’s disease. The rare disorder can lead to severe liver and brain damage. Alex...

Refilling Alexion’s cupboard

The first acquisition by Alexion’s new management team highlights both the need, and the difficulty, to reduce its Soliris dependence.

Alexion splurges in Sweden in bid to build up pipeline

Alexion Pharmaceuticals has offered 7.1 billion Swedish kronor ($855 million) to buy Stockholm-based…

PubMed Articles [1171 Associated PubMed Articles listed on BioPortfolio]

In Vitro Selection of Single-Domain Antibody (VHH) Using cDNA Display.

Single-domain antibody (e.g., Nanobody, VHH antibody) is a promising scaffold for therapeutic and diagnostic reagents. To expand the range of target molecules, in vitro selection using cell-free displ...

Fc Glyco- and Fc Protein-Engineering: Design of Antibody Variants with Improved ADCC and CDC Activity.

Monoclonal antibodies are established treatment options in cancer therapy. However, not all patients benefit from antibody therapy. Basic research and findings from clinical trials revealed that certa...

Antibody Glycoengineering Strategies in Mammalian Cells.

As a key parameter impacting functional and structural heterogeneity, protein glycosylation is a critical quality attribute for antibody biotherapeutic manufacturing. The glycan patterns on recombinan...

A sensitive and robust HPLC method to quantify recombinant antibody fragments in E. coli crude cell lysate.

Development of Polyclonal Antibody against Clenbuterol for Immunoassay Application.

Development of an immunoassay for clenbuterol (CLB) detection required an anti-CLB antibody as an important bioreceptor. In this study, we report our work on production and purification of a rabbit-de...

Clinical Trials [2063 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

JCV Antibody Program (STRATIFY-1)

Study conducted to define the prevalence of Serum JC Antibody in relapsing MS patients receiving Tysabri or being considered for such treatment. Analytically validate the JCV antibody ass...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Expanded Access Study of Iodine-131 Anti-B1 Antibody

The primary objective of this study is to make Iodine-131 Anti-B1 Antibody more broadly available to patients. Secondary endpoints of the study will be to obtain additional information on...

Companies [1686 Associated Companies listed on BioPortfolio]

Alexion Antibody Technologies, Inc.

Alexion Antibody Technologies, Inc. (AAT) is a wholly owned subsidiary of Alexion Pharmaceuticals [ALXN]. AAT is engaged in discovering and developing a portfolio of antibody therapeutics targeting se...

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed ...

Alexion Pharmaceuticals Incorporated

Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rar...

Antibody Solutions Inc

Antibody Solutions Inc., based in Mountain View in the San Francisco Bay Area, offers quality antibody development, antibody manufacture and immunoassay development that are optimized for your specifi...

Takeda San Francisco Inc.

Takeda San Francisco was established in November 2007 and supports Takeda's therapeutic antibody research aiming to build antibody technology platforms based on technologies such as discovery and ...

More Information about "Alexion Antibody Technologies, Inc." on BioPortfolio

We have published hundreds of Alexion Antibody Technologies, Inc. news stories on BioPortfolio along with dozens of Alexion Antibody Technologies, Inc. Clinical Trials and PubMed Articles about Alexion Antibody Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alexion Antibody Technologies, Inc. Companies in our database. You can also find out about relevant Alexion Antibody Technologies, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Corporate Database Quicklinks

Searches Linking to this Company Record